Fundz

Who to call at iOrganBio, and when

Fundz watches for the moments iOrganBio starts buying, and tells you who to reach.

  • An alert the day iOrganBio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at iOrganBio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at iOrganBio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

iORGANBIO Partners With Mitsui Chemicals to Develop AI-Enhanced Oxygen-Permeable Plates for Organoid Growth.

Nov 11, 2026

Contract Type

partnership

Chapel HillBiotechnology

Description

iORGANBIO has secured a strategic investment from Mitsui Chemicals, utilizing their combined technologies to address organoid reproducibility issues. This partnership follows the FDA's recent rule shift against animal testing, aiming to develop reliable alternatives for pharmaceutical applications.

Other recent agreements in Biotechnology

Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.

Company Information

Company

iOrganBio

Location

Chapel Hill, North Carolina, United States

About

iOrganBio is transforming human cell production with CellForge™, its AI-powered platform for consistent, scalable, and intelligent manufacturing of cells and organoids for in vitro modeling and cell therapies. By applying engineering precision to biology, CellForge uses AI and automation to guide cell development and make real-time adjustments aligned with defined biological profiles. At the core of the platform is iOrganBio’s functional human CellAtlas™, a comprehensive reference built from single-cell and multi-omics data that provides the digital blueprints for each cell type. This smart, closed-loop process delivers the accuracy, efficiency, and quality partners need to turn scientific ideas into breakthroughs, accelerating disease modeling, regenerative medicine, and drug development. iOrganBio is based at BioLabs in Chapel Hill, NC.

Related People

Daniel
Likely contact at this company
••••••••@••••••••

See Daniel's verified email →

Allison
Likely contact at this company
••••••••@••••••••

See Allison's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for iOrganBio's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

iOrganBio signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.